RIM2 (RAB3 Interacting Molecule 2) is a critical regulator of synaptic vesicle trafficking and neurotransmitter release in the central nervous system. This gene encodes a scaffolding protein that plays essential roles in synaptic function, and its dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders. [@gundelfinger2003]
RIM2 (RAB3 Interacting Molecule 2) is a critical regulator of synaptic vesicle trafficking and neurotransmitter release in the central nervous system. This gene encodes a scaffolding protein that plays essential roles in synaptic function, and its dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders. [@gundelfinger2003]
<div class="infobox infobox-gene"> [@sdhof2012]
<div class="infobox-header">Gene Information</div> [@jackman2016]
<div class="infobox-row"> [@deng2019]
<div class="infobox-label">Gene Symbol</div> [@liu2021]
<div class="infobox-value">RIM2</div> [@montag2018]
</div>
<div class="infobox-row">
<div class="infobox-label">Full Name</div>
<div class="infobox-value">RAB3 Interacting Molecule 2</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Chromosomal Location</div>
<div class="infobox-value">5q12.3</div>
</div>
<div class="infobox-row">
<div class="infobox-label">NCBI Gene ID</div>
<div class="infobox-value">26146</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Ensembl ID</div>
<div class="infobox-value">ENSG00000156413</div>
</div>
<div class="infobox-row">
<div class="infobox-label">UniProt ID</div>
<div class="infobox-value">Q9Y3M8</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Protein Aliases</div>
<div class="infobox-value">RIM2, RIMS2, Regulating Synaptic Membrane Exocytosis Protein 2</div>
</div>
<div class="infobox-row">
<div class="infobox-label">Associated Diseases</div>
<div class="infobox-value">Alzheimer's Disease, Parkinson's Disease, Synaptic Dysfunction, Autism Spectrum Disorder</div>
</div>
</div>
RIM2 (RAB3 Interacting Molecule 2) is a member of the RIM family of proteins that function as key scaffolds at the presynaptic active zone. RIM proteins are essential for synaptic vesicle priming, calcium-triggered neurotransmitter release, and short-term synaptic plasticity. RIM2 is one of the most abundant RIM isoforms in the brain and is critical for normal synaptic transmission.
RIM2 contains several functional domains:
RIM2 participates in multiple synaptic processes:
RIM2 directly interacts with RAB3A, RAB3B, RAB3C, and RAB3D GTPases through its N-terminal domain. This interaction is crucial for:
RIM proteins cooperate with Munc13 proteins to promote synaptic vesicle priming. The RIM-Munc13 complex is essential for:
RIM2 directly binds to P/Q-type (Cav2.1) and N-type (Cav2.2) voltage-gated calcium channels, positioning them near release sites.
RIM2 is highly expressed throughout the brain:
| Brain Region | Expression Level | Notes |
|--------------|-----------------|-------|
| [Hippocampus](/brain-regions/hippocampus) | High | CA1-CA3 pyramidal [neurons](/entities/neurons) |
| Cerebral [Cortex](/brain-regions/cortex) | High | Layer 2/3 and layer 5 pyramidal neurons |
| Cerebellum | High | Purkinje cells |
| Basal Ganglia | Moderate | Striatal medium spiny neurons |
| Brainstem | Moderate | Various nuclei |
RIM2 localizes specifically to:
Association: RIM2 dysfunction contributes to synaptic failure in AD
Mechanisms:
Association: RIM2 in dopaminergic neuron function
Mechanisms:
Association: RIM2 variants linked to ASD
Mechanisms:
RIM2 and its interacting proteins represent potential therapeutic targets:
| Strategy | Approach | Status |
|----------|----------|--------|
| RIM2 modulators | Small molecules enhancing function | Preclinical |
| RAB3 pathway | GTPase modulators | Research |
| Calcium channel coupling | Synaptic enhancer compounds | Preclinical |
| Gene therapy | AAV-mediated RIM2 expression | Research |
Rim2−/− mice show:
The study of Rim2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.